Literature DB >> 10466669

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies.

Z Walker, D C Costa, P Ince, I G McKeith, C L Katona.   

Abstract

With the dopaminergic presynaptic ligand FP-CIT and single photon emission tomography we have shown a severe dopaminergic degeneration in a patient with a necropsy confirmed diagnosis of dementia with Lewy bodies (DLB). We suggest that functional imaging of the nigrostriatal dopamine pathway helps to distinguish DLB from Alzheimer's disease during life.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10466669     DOI： 10.1016/s0140-6736(99)01178-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  10 in total

1.  Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer's disease.

Authors:  Kazutomi Kanemaru; Hiroshi Yamanouchi
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

Review 2.  Imaging of the dopaminergic system in differential diagnosis of dementia.

Authors:  Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

3.  99mTc-M-TRODAT is not superior to (99m)Tc-TRODAT-1 for the diagnosis of Parkinson's disease.

Authors:  A Maes; H Vanbilloen; B Cleynhens; L Mortelmans; G Bormans; A Verbruggen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-05       Impact factor: 9.236

Review 4.  Dementia with Lewy bodies - from scientific knowledge to clinical insights.

Authors:  Nikitas A Arnaoutoglou; John T O'Brien; Benjamin R Underwood
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

5.  Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

Authors:  Zuzana Walker; Evelyn Jaros; Rodney W H Walker; Lean Lee; Durval C Costa; Gill Livingston; Paul G Ince; Robert Perry; Ian McKeith; Cornelius L E Katona
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

6.  Dementia with Lewy bodies.

Authors:  Ian McKeith
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

7.  Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?

Authors:  Verena Bittner; Gerhard Ullrich; Markus Thormann; Notger G Müller; Christin Friederichs; Holger Amthauer; Hans-Jochen Heinze; Daniel M Bittner
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-09-21

8.  Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET).

Authors:  Siroos Mirzaei; Peter Knoll; Horst Koehn; Thomas Bruecke
Journal:  BMC Nucl Med       Date:  2003-02-20

9.  The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies.

Authors:  Angelo Antonini
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

Review 10.  Dementia with Lewy bodies: disease concept and genetics.

Authors:  Manuel B Graeber; Ulrich Müller
Journal:  Neurogenetics       Date:  2003-07-26       Impact factor: 2.660
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.